HEALTHPEAK PROPERTIES, INC.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent $627.7m
$414.2m -34.02%
$1.1b +156.20%
$45.5m -95.71%
$413.6m +808.33%
$505.5m +22.24%
$500.4m -1.01%
$306.0m -38.85%
$243.1m -20.54%
$71.3m -70.66%
Net Income (Loss) Available to Common Stockholders, Basic $626.5m
$413.0m -34.08%
$1.1b +156.27%
$44.0m -95.84%
$411.1m +834.70%
$502.3m +22.16%
$497.8m -0.89%
$304.3m -38.87%
$242.4m -20.34%
$70.5m -70.91%
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $639.9m $422.6m $1.1b $60.1m $428.3m $525.9m $516.4m $334.8m $267.3m $101.0m
Net Income (Loss) Attributable to Noncontrolling Interest $12.2m $8.5m $12.4m $14.5m
Depreciation and amortization $568.1m $534.7m $549.5m $660.0m $697.1m $684.3m $710.6m $749.9m $1.1b $1.1b $1.1b
Amortization of Debt Issuance Costs and Discounts $20.0m $14.6m $12.6m $10.9m $10.2m $9.2m $10.9m $11.9m $29.0m $31.9m
Amortization Cash Flow ($25.8m) ($30.8m) ($36.7m)
Amortization Of Intangibles ($25.8m) ($30.8m) ($36.7m) ($33.1m)
Depreciation Amortization Depletion $710.6m $724.1m $1.0b $1.0b $1.1b
Deferred Income Tax Expense (Benefit) ($13.7m) ($5.5m) ($21.4m) ($18.3m) ($1.7m) ($4.4m) ($5.7m) ($14.6m) ($1.7m) $3.8m ($1.3m)
Deferred Tax ($6.0m) ($14.6m) ($1.7m) $3.8m ($1.3m)
Share-based Payment Arrangement, Noncash Expense $22.9m $14.3m $16.6m $18.2m $17.4m $18.2m $26.5m $14.5m $15.5m $14.4m $22.2m
Share-based Payment Arrangement, Expense $23.0m $14.0m $15.0m $18.0m $21.0m $23.0m $32.0m $19.0m $20.0m $20.0m $22.2m
Share-based Payment Arrangement, Expensed and Capitalized, Amount $14.0m $20.0m $26.0m $26.0m $29.0m $28.0m $22.2m
Equity Method Investment, Other than Temporary Impairment $6.0m
Goodwill, Impairment Loss $0 $0 $0 $0 $0 $0 $0 ($4.6m)
Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss $50.9m $0 $0
Asset Impairment Charge $7.0m ($5.6m) $23.0m ($893k) ($4.6m)
Income (Loss) from Equity Method Investments $11.4m $10.9m ($2.6m) ($8.6m) ($66.6m) $6.1m $2.0m $10.2m ($1.5m) ($174.0m)
Nonoperating Income (Expense) $122.3m $333.8m $895.1m $146.7m $282.1m ($29.0m) $335.3m $93.3m $238.0m $70.0m
Other Nonoperating Income (Expense) $3.7m $31.4m $13.3m $182.1m $234.7m $6.3m $326.3m $6.8m $59.3m $479k
Earnings (Loss)es From Equity Investments ($2.0m) ($10.2m) $1.5m $174.0m $166.8m
Changes in operating assets and liabilities:
Change In Working Capital $118.9m $82.9m $44.8m $105.7m $116.8m
Increase (Decrease) in Accounts Receivable ($3.8m) ($20.0m)
Change In Receivables ($17.4m) ($21.6m) ($40.9m) ($16.3m) ($20.0m)
Changes In Account Receivables ($17.4m) ($21.6m) ($40.9m) ($16.3m) ($20.0m)
Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal $6.5m $2.1m $7.7m $3.1m
Net Cash Provided by (Used in) Operating Activities $1.2b
$847.0m -30.23%
$848.7m +0.20%
$846.1m -0.31%
$758.4m -10.36%
$795.2m +4.85%
$900.3m +13.21%
$956.2m +6.22%
$1.1b +11.95%
$1.3b +16.95%
$1.2b -1.67%
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $458.9m $471.8m $607.2m $744.0m $788.9m $759.7m $962.0m $774.6m $736.8m $894.9m
Gain (Loss) on Sale of Investments $164.7m $356.6m $926.0m $22.9m $550.5m $605.3m $10.4m $86.5m $178.7m $69.5m
Net Other Investing Changes ($1.8m) $96.4m ($65.8m) ($63.8m) $289.6m
Net Cash Provided by (Used in) Investing Activities ($410.6m) $1.2b $1.8b ($1.4b) ($1.0b) $531.0m ($876.3m) ($576.8m) ($113.8m) ($1.0b) ($1.1b)
Cash flows from financing activities:
Gain (Loss) on Extinguishment of Debt ($46.0m) ($54.2m) ($44.2m) ($58.4m) ($42.9m) ($225.8m) $0 $0
Issuance Of Debt $16.4b $11.1b $4.5b $13.1b $12.6b
Long Term Debt Issuance $16.4b $11.1b $4.5b $13.1b $12.6b
Long Term Debt Payments ($16.1b) ($10.7b) ($4.3b) ($12.0b) ($11.4b)
Net Issuance Payments Of Debt $324.6m $378.1m $153.2m $1.1b $967.4m
Net Long Term Debt Issuance $324.6m $378.1m $153.2m $1.1b $1.2b
Net Short Term Debt Issuance $1.0b ($170.4m) ($275.6m) ($424.0m)
Repayment Of Debt ($16.1b) ($10.7b) ($4.3b) ($12.0b) ($11.4b)
Short Term Debt Issuance $16.8b $15.9b $10.3b $5.7b
Short Term Debt Payments ($15.8b) ($16.1b) ($10.6b) ($6.1b)
Payments for Repurchase of Common Stock $8.7m $4.8m $3.4m $5.0m $10.5m $12.8m $67.8m $6.5m $190.7m $97.1m
Common Stock Dividend Paid ($648.0m) ($657.0m) ($794.8m) ($849.1m) ($846.0m)
Common Stock Issuance $308.1m $278k $317k $1.1m $1.6b
Common Stock Payments ($67.8m) ($6.5m) ($190.7m) ($97.1m) ($101.7m)
Issuance Of Capital Stock $308.1m $278k $317k $1.1m $1.6b
Net Common Stock Issuance $240.3m ($6.2m) ($190.4m) ($96.0m) $1.5b
Repurchase Of Capital Stock ($67.8m) ($6.5m) ($190.7m) ($97.1m) ($101.7m)
Dividends paid $979.5m $695.0m $696.9m $720.1m $787.1m $650.1m $648.0m $657.0m $794.8m $849.1m ($846.0m)
Cash Dividends Paid ($648.0m) ($657.0m) ($794.8m) ($849.1m) ($846.0m)
Dividend Received CFO $943k $910k $12.0m $17.1m $8.3m
Dividends Received CFI $12.5m $20.6m $22.9m $28.5m $28.9m
Net Other Financing Charges ($33.3m) ($52.1m) ($109.5m) ($27.5m) ($189.9m)
Net Cash Provided by (Used in) Financing Activities ($1.1b)
($2.1b) -103.79%
($2.6b) -21.97%
$647.3m +124.70%
$246.4m -61.92%
($1.3b) -622.83%
($116.5m) +90.96%
($337.3m) -189.45%
($941.4m) -179.10%
$136.1m +114.46%
$1.4b +946.25%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect ($54.8m) $57.6m $44.8m ($3.0m) $37.8m ($92.6m) $42.2m $15.3m $353.4m $1.7b
Beginning Cash Position $219.4m $126.8m $169.0m $184.3m $163.3m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $82.2m $139.8m $184.7m $111.4m $211.7m $126.8m $169.0m $184.3m $1.7b
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $245k ($153k) $0 $0
Effect Of Exchange Rate Changes $0 $0
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $489.5m $309.1m $275.7m $201.8m $209.8m $173.0m $162.1m $188.2m $249.5m $260.1m
Income Taxes Paid, Net $13.7m $10.0m $4.5m $1.4m ($786k) $4.5m ($1.9m) $1.9m $7.9m $3.4m
Additional Financial Items
Deconsolidation, Gain (Loss), Amount $311.0m $78.0m
Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax $400.7m $0 $0
Foreign Currency Transaction Gain (Loss), before Tax ($188k)
Gains (Losses) on Sales of Investment Real Estate $164.7m $356.6m $926.0m $22.9m $90.3m $190.6m $9.1m $86.5m $178.7m $69.5m
General and Administrative Expense $103.6m $88.8m $96.7m $93.0m $93.2m $98.3m $131.0m $95.1m $97.2m $90.4m
Goodwill $42.4m $47.0m $47.0m $47.0m $18.0m $18.0m $18.0m $18.0m $68.5m $68.5m ($4.6m)
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent $362.0m $414.2m $1.1b $45.5m $146.1m $119.9m $497.6m $306.0m $243.1m $71.3m
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $374.2m $422.6m $1.1b $60.1m $160.5m $137.7m $513.5m $334.8m $267.3m $101.0m
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $265.8m $0 $0 $267.7m $388.2m $2.9m $0 $0
Income Tax Expense (Benefit) $4.5m ($1.3m) ($17.9m) ($17.3m) ($9.4m) ($3.3m) ($4.4m) ($9.6m) $4.3m $9.3m
Insured Event, Gain (Loss) ($12.1m) $0 $3.7m ($469k) ($1.6m) ($7.2m) $3.1m ($29.1m) ($621k)
Noncash Merger Related Costs $16.2m $0
Operating Costs and Expenses $1.1b
Operating Expenses $738.4m $666.3m $705.0m $879.4m $782.5m $773.3m $863.0m $902.1m
Operating Lease, Lease Income $1.2b $1.2b $1.4b $1.5b $1.6b $2.1b $2.2b
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax ($707k) ($799k) ($18.1m) ($1.0m)
Proceeds from Noncontrolling Interests $1.6m $299.7m $33.3m $0 $640k $1.4m $489k $12k $13.1m
Proceeds from (Payments to) Noncontrolling Interests $11.8m
Provision for Loan, Lease, and Other Losses $8.9m
Financing Receivable, Credit Loss, Expense (Reversal) $1.7m
Cash Flow From Continuing Financing Activities ($116.5m) ($337.3m) ($941.4m) $136.1m $1.4b
Cash Flow From Continuing Investing Activities ($876.3m) ($576.8m) ($113.8m) ($1.0b) ($1.1b)
Change In Account Payable $136.3m ($40.7m) ($28.6m) ($25.3m) ($86.3m)
Change In Cash Supplemental As Reported ($92.6m) $42.2m $15.3m $353.4m
Change In Other Working Capital $145.2m $114.3m $147.3m $223.1m
Change In Payable $136.3m ($40.7m) ($28.6m) ($25.3m) ($86.3m)
Changes In Cash ($92.6m) $42.2m $15.3m $353.4m $1.6b
End Cash Position $126.8m $169.0m $184.3m $537.7m $1.7b
Financing Cash Flow ($116.5m)
($337.3m) -189.45%
($941.4m) -179.10%
$136.1m +114.46%
$1.4b +946.25%
Free Cash Flow $900.3m $956.2m $1.1b $1.3b $1.2b
Gain Loss On Investment Securities ($33.1m) ($86.5m) ($178.7m) ($69.5m) ($128.5m)
Gain Loss On Sale Of Business ($311.4m) ($234k) ($77.5m) $0 ($138.3m)
Investing Cash Flow ($876.3m) ($576.8m) ($113.8m) ($1.0b) ($1.1b)
Net Business Purchase And Sale $104.8m ($88.4m) ($115.2m) ($86.8m) ($167.8m)
Net Investment Properties Purchase And Sale ($991.9m) ($605.4m) $44.3m ($912.6m) ($1.3b)
Net Investment Purchase And Sale $0 $0
Operating Gains Losses ($346.6m) ($96.9m) ($254.7m) $104.5m ($99.6m)
Other Non Cash Items ($127.4m) ($83.9m) ($78.4m) ($115.9m)
Purchase Of Business ($21.1m) ($88.4m) ($240.8m) ($86.8m) ($330.6m)
Purchase Of Investment $0 $0 ($1.7b)
Purchase Of Investment Properties ($1.0b) ($747.1m) ($604.3m) ($1.3b) ($1.7b)
Sale Of Business $126.0m $0 $125.7m $0 $162.8m
Sale Of Investment Properties $47.9m $141.7m $648.5m $337.7m $479.6m
Stock Based Compensation $26.5m $14.5m $31.8m $14.4m $22.2m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.